Raymond James Financial Services Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$14.9K Buy
1,436
+50
+4% +$831 ﹤0.01% 3409
2024
Q2
$27.3K Buy
1,386
+3
+0.2% +$60 ﹤0.01% 3333
2024
Q1
$35.4K Buy
1,383
+25
+2% +$641 ﹤0.01% 3320
2023
Q4
$37.5K Buy
1,358
+86
+7% +$5.24K ﹤0.01% 3207
2023
Q3
$77.4K Sell
1,272
-93
-7% -$6.53K ﹤0.01% 3108
2023
Q2
$89.8K Sell
1,365
-20
-1% -$1.46K ﹤0.01% 3079
2023
Q1
$88.1K Sell
1,385
-202
-13% -$23.1K ﹤0.01% 3064
2022
Q4
$220K Sell
1,587
-204
-11% -$28.7K ﹤0.01% 2814
2022
Q3
$227K Buy
1,791
+108
+6% +$12.2K ﹤0.01% 2764
2022
Q2
$139K Buy
+1,683
New +$131K ﹤0.01% 2953
2020
Q1
Sell
-705
Closed -$801K 2449
2019
Q4
$801K Buy
705
+379
+116% +$412K ﹤0.01% 1674
2019
Q3
$387K Sell
326
-8
-2% -$12.2K ﹤0.01% 2071
2019
Q2
$551K Buy
334
+145
+77% +$251K ﹤0.01% 1862
2019
Q1
$385K Buy
189
+23
+14% +$40.5K ﹤0.01% 2054
2018
Q4
$213K Buy
166
+38
+30% +$58.3K ﹤0.01% 2216
2018
Q3
$242K Sell
128
-46
-26% -$95K ﹤0.01% 2404
2018
Q2
$354K Sell
174
-53
-23% -$121K ﹤0.01% 2119
2018
Q1
$503K Sell
227
-14
-6% -$35.6K ﹤0.01% 1716
2017
Q4
$555K Buy
241
+71
+42% +$144K ﹤0.01% 1653
2017
Q3
$302K Buy
170
+15
+10% +$21K ﹤0.01% 2019
2017
Q2
$211K Buy
+155
New +$187K ﹤0.01% 2191

Other funds holding BLUE

Raymond James Financial Services Advisors's BLUE Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its bluebird bio (BLUE) stake by 3.6% in Q3 2024, buying an estimated $831 and bringing the position to 1,436 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Raymond James Financial Services Advisors first reported a position in BLUE in Q2 2017 and has held it in 21 quarters since. The position peaked at $801K in Q4 2019. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • Raymond James Financial Services Advisors held 1,436 shares of bluebird bio worth $14.9K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 50 bluebird bio shares in Q3 2024, an estimated $831.
  • bluebird bio made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3409 holding.
  • Raymond James Financial Services Advisors first reported a position in bluebird bio in Q2 2017 and has held it in 21 quarters since.
  • Raymond James Financial Services Advisors's bluebird bio position peaked at $801K in Q4 2019.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.